USP17L9P: A Promising Protein for Drug Targets and Biomarkers
USP17L9P: A Promising Protein for Drug Targets and Biomarkers
USP17L9P (RS447) is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the USP family of transmembrane proteins, which are involved in the regulation of cell signaling pathways. USP17L9P is unique because it is a potent inhibitor of the protein kinase PDK4, which is involved in many cellular processes, including cell growth, differentiation, and survival.
In recent years, researchers have been interested in USP17L9P because of its potential as a drug target or biomarker. Studies have shown that USP17L9P can inhibit the effects of PDK4, which could be useful for treating a variety of diseases. For example, USP17L9P has been shown to be a potential therapeutic for cancer, as it can inhibit the growth and survival of cancer cells.
In addition to its potential as a drug target, USP17L9P has also been studied as a potential biomarker for a variety of diseases. For example, USP17L9P has been shown to be expressed in the brains of individuals with Alzheimer's disease, and may be a useful biomarker for this disease. Additionally, USP17L9P has been shown to be expressed in the blood vessels of individuals with cardiovascular disease, which may make it a useful biomarker for this disease.
Despite its potential as a drug target or biomarker, USP17L9P is still a relatively little-studied protein. There are only a few studies that have investigated its effects and potential uses. However, these studies suggest that USP17L9P may have a promising future as a drug or biomarker.
In conclusion, USP17L9P is a unique and promising protein that has the potential to be a drug target or biomarker. Its unique ability to inhibit the protein kinase PDK4 makes it a promising target for the development of new therapies. Further research is needed to fully understand its effects and potential uses.
Protein Name: Ubiquitin Specific Peptidase 17 Like Family Member 9, Pseudogene
The "USP17L9P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about USP17L9P comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
USP18 | USP19 | USP2 | USP2-AS1 | USP20 | USP21 | USP22 | USP24 | USP25 | USP26 | USP27X | USP27X-DT | USP28 | USP29 | USP3 | USP3-AS1 | USP30 | USP30-AS1 | USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34 | USP35 | USP36 | USP37 | USP38 | USP39 | USP4 | USP40 | USP41 | USP42 | USP43 | USP44 | USP45 | USP46 | USP46-DT | USP47 | USP48 | USP49 | USP5 | USP50 | USP51 | USP53 | USP54 | USP6 | USP6NL | USP6NL intronic transcript 1 (non-protein coding), transcript variant 1 | USP7 | USP8 | USP8P1 | USP9X | USP9Y | USPL1 | UST | UTF1 | UTP11 | UTP14A | UTP14C | UTP15 | UTP18 | UTP20 | UTP23 | UTP25 | UTP3 | UTP4 | UTP6 | UTRN | UTS2 | UTS2B | UTS2R | UTY | UVRAG | UVSSA | UXS1 | UXT | UXT-AS1 | VAC14 | Vacuolar H+ ATPase | VAMP1 | VAMP2 | VAMP3 | VAMP4 | VAMP5 | VAMP7 | VAMP8 | VANGL1 | VANGL2 | VAPA | VAPB | VARS1 | VARS2 | Vascular endothelial growth factor receptor (VEGFR) | Vascular endothelial growth factors (VEGF) | VASH1 | VASH1-AS1 | VASH2 | VASN
